Drugs Of Abuse Testing Market Report

Market Insights

The Global Drugs of Abuse Testing Market is expected to grow from USD 3.1 billion in 2020 to USD 4.3 billion by 2026 at a CAGR of over 5.6% during the forecast period.

Figure: Global Drugs of Abuse Testing Market Size, 2020-2026 (USD Billion)

Want to know the full scope of the report? Register Here

What are the Drugs of abuse testing?

Drugs of abuse testing are done to detect one or more illegal substances in the urine, saliva, blood, hair, or sweat. It usually involves initial drug screening and then a second test to confirm the presence of a drug or drugs. Some of the commonly screened tests include psych stimulants, narcotics, sedatives, and cannabinoids.

Key Players

Key players operating in the global Drugs of abuse testing market are-

• Abbott Laboratories (The US),
• Quest Diagnostics (The US),
• Siemens AG (Germany),
• F. Hoffmann-La Roche AG (Switzerland),
• Thermo Fisher Scientific, Inc. (The US),
• Shimadzu Corporation, Express Diagnostics International Inc. (Japan),
• Drägerwerk AG & Co. KGaA (Germany),
• Laboratory Corporation of America Holdings (The US),
• DANAHER CORPORATION (The US), and
• BIO-RAD LABORATORIES INC. (The US).

Market Dynamics

The growth of the global drug of abuse testing market is primarily driven by an increase in the consumption of illicit drugs and alcohol.

• Increasing initiatives by the government to monitor and fight drug abuse is likely to propel the market growth at a significant rate.
• For instance, in India, on the occasion of International Day against Drug Abuse and Illicit Trafficking, an annual Anti-Drug Action Plan for 2020-21 for 272 districts was launched by the Ministry of Social Justice and Empowerment to curb drug abuse and alcoholism.
• Increasing safety standards at workplaces is also likely to fuel the product demand substantially.

Segment Analysis

Sample Type Trends

Based on sample type, the market has been segmented into urine, hair, oral fluid, and others.

• The urine segment accounted for the largest market share in 2020 and is expected to continue its dominance during the review period.
• This segmental growth can be attributed to the availability of point-of-care tests and low sample test prices.

Regional Trends

Geographically, the market in North America accounted for the largest share in 2020 due to the high consumption of drugs and alcohol.

• Additionally, supporting government measures to curb the use of drugs is likely to add significantly to the market growth.
• The market in Europe accounted for the second-largest market share in 2020.

COVID-19 Impact on Global Drugs of abuse testing Market

The covid-19 outbreak affected the growth of the drug of abuse testing market for a short period due to disruption in business and economic activities across geographies. Postponement of non-essential medical services amid the covid-19 outbreak also affected the growth of the drug abuse testing market.

Critical Questions Answered in the Report

• What are the key trends in the global drugs of abuse testing market?
• How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
• What is the impact of COVID-19 on global drugs of abuse testing market?
• What are the key strategies adopted by the major vendors to lead in the global drugs of abuse testing market?
• What is the market share of the top vendors?

Get the full scope of the report. Register Here

Target Audience

The following is a list of the customers that the Drugs of Abuse Testing market aims to convert the most:

• Drugs of abuse testing manufacturers
• Drugs of abuse testing suppliers
• Drugs of abuse testing distributors
• Organizations
• Government bodies

Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.